Evdakov, V.A.,
Starodubov, V.I.,
Oleynik, B.A.,
Sharafutdinova, N.Kh.,
Borisova, M.V.,
Plechev, V.V. (2023) with cardiovascular diseases in
population, which have high risk and benefit from the control of the highest risk
Ivanova, E.,
Gilyazova, I.,
Pavlov, V.,
Izmailov, A.,
Gimalova, G.,
Karunas, A.,
Prokopenko, I.,
Khusnutdinova, E. (2022) risk of developing disease outcomes from the general
population. Clear cell renal cell carcinoma (cc
Dzhemilev, Usein M.,
D’yakonov, Vladimir A.,
Tuktarova, Regina A.,
Dzhemileva, Lilya U.,
Ishmukhametova, Svetlana R.,
Yunusbaeva, Milyausha M.,
Armin de Meijere (2016) developed. The
key step in the five-step 41% overall yield synthesis is the catalytic cross
at an early stage of the illness. In different
populations the clinical characteristics of patients with HD